邻近类别 專利 [0/1] 會議論文/會議摘要 [1/1] 类别统计 近3年内发表的文件:11(50.00%) 含全文笔数:22(100.00%) 文件下载次数统计 下载大于0次:22(100.00%) 下载大于100次:18(81.82%) 全文下载总次数:4751(99.73%) 最后更新时间: 2025-04-19 23:50 上传排行 数据加载中..... 下载排行 数据加载中..... 最近上传 Tumor cell-derived ISG15 promotes f... Upregulation of cathepsin S express... Synthesis, anticancer evaluation an... Advancing precision therapy for col... Macrophage-mediated controlled rele... Targeting cathepsin S promotes acti... Lysosomal-targeted doxorubicin deli... How to deal with frenemy NRF2: Targ... Synthesis and structure–activity re... The synergistic inhibition of coron...

跳至: (选择年份) 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (选择月份) January February March April May June July August September October November December 或输入年份:

由新到旧排序 由最旧的开始

显示项目1-22 / 22. (共1页) 1  每页显示[10|25|50]项目

日期	题名	關聯
2025-03-11	Tumor cell-derived ISG15 promotes fibroblast recruitment in oral squamous cell carcinoma via CD11a-dependent glycolytic reprogramming	Oncogenesis. 2025 Mar 11;14:Article number 6.
2025-03-05	Upregulation of cathepsin S expression contributes to neuronal damage following kainic acid-induced status epilepticus	Journal of Neurochemistry. 2025 Mar 05;169(3):Article number e70037.
2025-02-03	Synthesis, anticancer evaluation and structure-activity relationship of Taiwanin a derivatives	Chemistry of Natural Compounds. 2025 Feb 03;61:11-18.
2025-01	Advancing precision therapy for colorectal cancer: Developing clinical indications for multi-target kinase inhibitor BPR1J481 using patient-derived xenograft models	Pharmacological Research. 2025 Jan;211:Article number 107556.
2024-06-24	Macrophage-mediated controlled release of cysteine protease inhibitor from PLGA-PEG/hydroxyapatite microspheres for targeting cathepsin S in Alzheimer's disease	European Polymer Journal. 2024 Jun 24;214:Article number 113151.
2024-05-09	Targeting cathepsin S promotes activation of OLF1-BDNF/TrkB axis to enhance cognitive function	Journal of Biomedical Science. 2024 May 09;31:Article number 46.
2023-11	Lysosomal-targeted doxorubicin delivery using RBC-derived vesicles to overcome drug-resistant cancer through mitochondrial-dependent cell death	Pharmacological Research. 2023 Nov;197:Article number 106945.
2023-03-28	Synthesis and structure–activity relationship of salvinal derivatives as potent microtubule inhibitors	International Journal of Molecular Sciences. 2023 Mar 28;24(7):Article number 6386.
2023-02-28	How to deal with frenemy NRF2: Targeting NRF2 for chemoprevention and cancer therapy	Journal of Food and Drug Analysis. 2023 Feb 28;31(3):387-407.
2023-02-03	MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma and accelerate clinical cancer invasion by regulating partial epithelial-to-mesenchymal transition	Journal of Experimental and Clinical Cancer Research. 2023 Feb 3;42:Article number 40.
2023-01-19	The synergistic inhibition of coronavirus replication and induced cytokine production by ciclesonide and the tylophorine-based compound dbq33b [Erratum:Pharmaceutics. 2022 Jul 21;14(7):Article number 1511.]	Pharmaceutics. 2023 Jan 19;15(2):Article number 342.
2022-07-21	The synergistic inhibition of coronavirus replication and induced cytokine production by ciclesonide and the tylophorine-based compound dbq33b	Pharmaceutics. 2022 Jul 21;14(7):Article number 1511.
2022-03-16	Lon upregulation contributes to cisplatin resistance by triggering NCLX-mediated mitochondrial Ca2+ release in cancer cells	Cell Death and Disease. 2022 Mar 16;13(3):Article number 241.
2022-03-02	Discovery of potential neuroprotective agents against paclitaxel-induced peripheral neuropathy	Journal of Medicinal Chemistry. 2022 Mar 2;65(6):4767-4782.
2021-12-14	A novel NRF2/ARE inhibitor gossypol induces cytotoxicity and sensitizes chemotherapy responses in chemo-refractory cancer cells	Journal of Food and Drug Analysis. 2021 Dec 14;29(4):638-652.
2021-11-09	MicroRANs: Their role in metabolism, tumor microenvironment, and therapeutic implications in head and neck squamous cell carcinoma	Cancers. 2021 Nov 9;13(22):Article number 5604.
2021-08-13	Remdesivir and cyclosporine synergistically inhibit the human coronaviruses OC43 and SARS-CoV-2	Frontiers in Pharmacology. 2021 Aug 13;12:Article number 706901.
2021-06	Investigating the association between serum human papillomavirus type 16 E7 antibodies and risk of head and neck cancer	Cancer Medicine. 2021 Jun;10(12):4075-4086.
2021-03-11	c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation	Theranostics. 2021 Mar 11;11(11):5232-5247.
2021-03-04	Targeting lysosomal cysteine protease cathepsin S reveals immunomodulatory therapeutic strategy for oxaliplatin-induced peripheral neuropathy	Theranostics. 2021 Mar 4;11(10):4672-4687.
2021-03-01	Phase I dose escalation study of sorafenib plus S-1 for advanced solid tumors	Scientific Reports. 2021 Mar 1;11:Article number 4834.
2021-02-24	New insights into oral squamous cell carcinoma: From clinical aspects to molecular tumorigenesis	International Journal of Molecular Sciences. 2021 Feb 24;22(5):Article number 2252.

显示项目1-22 / 22. (共1页) 1  每页显示[10|25|50]项目